Abstract

Wiskott–Aldrich syndrome (WAS) is a Х-linked combined immunodeficiency, characterized by thrombocytopenia, eczema, infections and predisposition to autoimmunity and tumors. The severity of the disease correlates with localization of the mutations in the WAS gene. In the most cases WAS is lethal during the first years of life, except of rare patients with the milder XLT. HSCT is a curative option for the majority of patients with WAS. In some cases conservative management is possible. This article presents a family case of the milder form of Wiskott–Aldrich syndrome.14 y.o. patient's condition is described in details.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call